Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer

被引：0
|
作者：
Forse, C. L.
Agarwal, S.
Pinnaduwage, D.
Gertler, F.
Condeelis, J.
Lin, J.
Xue, X.
Rohan, T. E.
Rimm, D. L.
Andrulis, I. L.
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Yale Univ, New Haven, CT USA
[3] MIT, Cambridge, MA 02139 USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
MODERN PATHOLOGY | 2014年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
187
引用
收藏
页码：49A / 49A
页数：1
相关论文
共 50 条
  • [1] Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
    Catherine L. Forse
    Seema Agarwal
    Dushanthi Pinnaduwage
    Frank Gertler
    John S. Condeelis
    Juan Lin
    Xiaonan Xue
    Kimberly Johung
    Anna Marie Mulligan
    Thomas E. Rohan
    Shelley B. Bull
    Irene L. Andrulis
    BMC Cancer, 15
  • [2] Menacalc, a Quantitative Method of Metastasis Assessment, as a Prognostic Marker for Axillary Node-Negative Breast Cancer
    Forse, C. L.
    Agarwal, S.
    Pinnaduwage, D.
    Gertler, F.
    Condeelis, J.
    Lin, J.
    Xue, X.
    Rohan, T. E.
    Rumm, D. L.
    Andrulis, I. L.
    LABORATORY INVESTIGATION, 2014, 94 : 49A - 49A
  • [3] Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer
    Forse, Catherine L.
    Agarwal, Seema
    Pinnaduwage, Dushanthi
    Gertler, Frank
    Condeelis, John S.
    Lin, Juan
    Xue, Xiaonan
    Johung, Kimberly
    Mulligan, Anna Marie
    Rohan, Thomas E.
    Bull, Shelley B.
    Andrulis, Irene L.
    BMC CANCER, 2015, 15
  • [4] Axillary metastasis in clinically node-negative breast cancer
    Ureyen, Orhan
    Cavdar, Demet Kocatepe
    Adibelli, Zehra Hilal
    Ilhan, Enver
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (04) : 159 - 163
  • [5] PROGNOSTIC FACTORS IN AXILLARY NODE-NEGATIVE BREAST-CANCER
    ZIELINSKI, CC
    ONKOLOGIE, 1994, 17 (03): : 284 - 285
  • [6] Clinical relevance of prognostic factors in axillary node-negative breast cancer
    Thomssen, C
    Jänicke, F
    Harbeck, N
    ONKOLOGIE, 2003, 26 (05): : 438 - 445
  • [7] Urokinase plasminogen activator: a prognostic marker in breast cancer including patients with axillary node-negative disease
    Duffy, MJ
    Duggan, C
    Mulcahy, HE
    McDermott, EW
    O'Higgins, NJ
    CLINICAL CHEMISTRY, 1998, 44 (06) : 1177 - 1183
  • [8] Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
    Seema Agarwal
    Frank B Gertler
    Michele Balsamo
    John S Condeelis
    Robert L Camp
    Xiaonan Xue
    Juan Lin
    Thomas E Rohan
    David L Rimm
    Breast Cancer Research, 14
  • [9] Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer
    Agarwal, Seema
    Gertler, Frank B.
    Balsamo, Michele
    Condeelis, John S.
    Camp, Robert L.
    Xue, Xiaonan
    Lin, Juan
    Rohan, Thomas E.
    Rimm, David L.
    BREAST CANCER RESEARCH, 2012, 14 (05):
  • [10] PROGNOSTIC FACTORS FOR RECURRENCE AND SURVIVAL IN AXILLARY NODE-NEGATIVE BREAST-CANCER
    MCGUIRE, WL
    CLARK, GM
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 34 (1-6): : 145 - 148
12345